Point72 Asset Management’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $791K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $59 | Sell |
|
|||||
|
2024
Q4 | $25.2K | Sell |
|
|||||
|
2024
Q3 | $55M | Buy |
|
|||||
|
2024
Q2 | $16.9M | Sell |
|
|||||
|
2024
Q1 | $64.3M | Buy |
|
|||||
|
2023
Q4 | $3.23M | Sell |
|
|||||
|
2023
Q3 | $4.77M | Sell |
|
|||||
|
2023
Q2 | $14M | Buy |
|
|||||
|
2023
Q1 | $8.78M | Sell |
|
|||||
|
2022
Q4 | $25M | Buy |
|
|||||
|
2022
Q3 | $3.46M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $3.69M | Sell |
|
|||||
|
2021
Q3 | $5.88M | Sell |
|
|||||
|
2021
Q2 | $17.1M | Buy |
|
|||||
|
2021
Q1 | $13.7M | Buy |
|
|||||
|
2020
Q4 | $15.1M | Buy |
|
|||||
|
2020
Q3 | $3.12M | Sell |
|
|||||
|
2020
Q2 | $5.71M | Buy |
|